These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

433 related articles for article (PubMed ID: 15089732)

  • 1. The medical profession and the pharmaceutical industry: when will we open our eyes?
    Breen KJ
    Med J Aust; 2004 Apr; 180(8):409-10. PubMed ID: 15089732
    [TBL] [Abstract][Full Text] [Related]  

  • 2. On the need for probity when physicians interact with industry.
    Scott IA
    Intern Med J; 2006 Apr; 36(4):265-9. PubMed ID: 16640747
    [TBL] [Abstract][Full Text] [Related]  

  • 3. "Under the radar": nurse practitioner prescribers and pharmaceutical industry promotions.
    Ladd EC; Mahoney DF; Emani S
    Am J Manag Care; 2010 Dec; 16(12):e358-62. PubMed ID: 21291293
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The high cost of free lunch.
    Frohlich EP
    Obstet Gynecol; 2007 Oct; 110(4):931; author reply 932-3. PubMed ID: 17906038
    [No Abstract]   [Full Text] [Related]  

  • 5. The high cost of free lunch.
    Campbell WA
    Obstet Gynecol; 2007 Oct; 110(4):931-2; author reply 932-3. PubMed ID: 17906037
    [No Abstract]   [Full Text] [Related]  

  • 6. The high cost of free lunch.
    Randall DA
    Obstet Gynecol; 2007 Oct; 110(4):932; author reply 932-3. PubMed ID: 17906039
    [No Abstract]   [Full Text] [Related]  

  • 7. The high cost of free lunch.
    Rankin RC
    Obstet Gynecol; 2007 Oct; 110(4):932. PubMed ID: 17906040
    [No Abstract]   [Full Text] [Related]  

  • 8. Getting drug money out of doctors' offices...
    Nagarkar PA
    Pharos Alpha Omega Alpha Honor Med Soc; 2010; 73(1):13-7. PubMed ID: 20178201
    [No Abstract]   [Full Text] [Related]  

  • 9. Doctors and the drug industry: further thoughts for dealing with potential conflicts of interest?
    Alpert JS
    Am J Med; 2008 Apr; 121(4):253-5. PubMed ID: 18374678
    [No Abstract]   [Full Text] [Related]  

  • 10. Re "Getting drug money out of doctors' offices".
    Jacobs J
    Pharos Alpha Omega Alpha Honor Med Soc; 2010; 73(3):50; author reply 50-1. PubMed ID: 20690557
    [No Abstract]   [Full Text] [Related]  

  • 11. [Effects of a mandatory guideline that prohibit hospital doctors from accepting any form of benefits in any form from the pharmaceutical industry].
    Gundermann C; Meier-Hellmann A; Bauer M; Hartmann M
    Dtsch Med Wochenschr; 2010 May; 135(3):67-70. PubMed ID: 20077378
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Medicine and the pharmaceutical industry: a call to action.
    Stiles MM; Barrett B
    Am Fam Physician; 2007 May; 75(10):1447, 1451; discussion 1451. PubMed ID: 17555137
    [No Abstract]   [Full Text] [Related]  

  • 13. Marketing of antipsychotic drugs targeted doctors of Medicaid patients, report says.
    Roehr B
    BMJ; 2012 Oct; 345():e6633. PubMed ID: 23033376
    [No Abstract]   [Full Text] [Related]  

  • 14. Response to open peer commentaries on "The pitfalls of deducing ethics from economics: why the Association of American Medical Colleges is wrong about pharmaceutical detailing".
    Huddle TS
    Am J Bioeth; 2010 Jan; 10(1):W1-3. PubMed ID: 20077322
    [No Abstract]   [Full Text] [Related]  

  • 15. Patient awareness and concern regarding pharmaceutical manufacturer interactions with doctors.
    Edwards D; Ballantyne A
    Intern Med J; 2009 Mar; 39(3):191-6. PubMed ID: 19383067
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Physicians, the industry and population health.
    Gérvas J; Mansfield PR
    J Epidemiol Community Health; 2009 Oct; 63(10):773-4. PubMed ID: 19749125
    [No Abstract]   [Full Text] [Related]  

  • 17. The high cost of free lunch.
    Wall LL; Brown D
    Obstet Gynecol; 2007 Jul; 110(1):169-73. PubMed ID: 17601912
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Contact with pharmaceutical representatives: where does prudence lead?
    Appelbaum PS
    Am J Bioeth; 2010 Jan; 10(1):11-3. PubMed ID: 20077326
    [No Abstract]   [Full Text] [Related]  

  • 19. Banning pens and pads misses the main point.
    Terry SF; Burke W
    Am J Bioeth; 2003; 3(3):63-5. PubMed ID: 14594500
    [No Abstract]   [Full Text] [Related]  

  • 20. [Clinical practice and pharmaceutical industry: an always difficult relationship].
    Mastai R
    Acta Gastroenterol Latinoam; 2005; 35(4):209-10. PubMed ID: 16496851
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 22.